 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
One possibility is to detect a protein made by inflammatory cells that kill bacteria. When bacteria are present, inflammatory cells rapidly start making a protein that causes inflammation. This protein, called triggering receptor expressed on myeloid cells-1 (TREM-1), is present on the surface of the inflammatory cells. As these cells circulate in the blood, some of the TREM-1 gets into the blood. Blood levels of TREM-1 are high during bacterial infection and low in other causes of SIRS.
SUMMARIES FOR PATIENTS
A Possible New Test for Diagnosing Sepsis
6 July 2004 | Volume 141 Issue 1 | Page I-46
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis." It is in the 6 July 2004 issue of Annals of Internal Medicine (volume 141, pages 9-15). The authors are S. Gibot, M.-N. Kolopp-Sarda, M.C. Béné, A. Cravoisy, B. Levy, G.C. Faure, and P.-E. Bollaert.
What is the problem and what is known about it so far?
Bacterial infection of the blood can result in a condition called sepsis, the most common cause of death in intensive care units. This type of infection can lead the body to make chemicals that cause a severe form of inflammation, called the systemic inflammatory response syndrome (SIRS). This syndrome occurs in patients with sepsis and in sick people who do not have sepsis. Telling the difference between SIRS with sepsis and SIRS with no sepsis is important because patients with sepsis need immediate treatment with antibiotics. It can be very difficult to know if a patient with SIRS also has sepsis, so a test for sepsis would be helpful. Doctors do test for bacteria in the blood, but this test can take many hours to become positive. The ideal test would give an answer right away, so that doctors could decide whether to use antibiotics and be fairly sure they made the right decision. Doctors usually start antibiotics immediately when they suspect sepsis, so many patients who don't have sepsis get antibiotics for several days until results of blood tests for bacteria are negative. Exposure to antibiotics can be harmful.
Why did the researchers do this particular study?
To determine whether the blood level of TREM-1 was a good test for sepsis in patients with SIRS.
Who was studied?
76 patients who were admitted to intensive care units because their doctors thought they might have infections of the blood.
What did the researchers do?
The researchers took a careful history, performed tests to measure the severity of illness, and drew blood to test for TREM-1 and for bacteria in the blood. Two expert physicians reviewed all of the information (except blood TREM-1 levels) and diagnosed SIRS (without bacterial infection of the blood) in 29 patients, bacterial infection of the blood in 22 patients, and bacterial blood infection with shock (the most severe form of bacterial blood infection) in 25 patients.
What did the researchers find?
A blood TREM-1 level above a certain value was a very good test for bacterial infection of the blood. It detected almost all the patients with sepsis (96%). Only 11% of patients with SIRS but not sepsis had increased TREM-1 levels. This means that a doctor would be correct 97% of the time if she said that a patient with an increased TREM-1 level had sepsis.
What were the limitations of the study?
Since the patients were all quite sick, it is not possible to say how the test would work in less ill patients. The authors also did not study patients older than 80 years of age or patients who had weak immunity.
What are the implications of the study?
The test for TREM-1 may help doctors to correctly diagnose sepsis much more quickly, which means that they can avoid giving antibiotics to people who don't have sepsis.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  C.-C. Ho, W.-Y. Liao, C.-Y. Wang, Y.-H. Lu, H.-Y. Huang, H.-Y. Chen, W.-K. Chan, H.-W. Chen, and P.-C. Yang TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 763 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Christ-Crain and B. Muller Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Eur. Respir. J., September 1, 2007; 30(3): 556 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Haselmayer, L. Grosse-Hovest, P. von Landenberg, H. Schild, and M. P. Radsak TREM-1 ligand expression on platelets enhances neutrophil activation Blood, August 1, 2007; 110(3): 1029 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Murakami, H. Kohsaka, H. Kitasato, and T. Akahoshi Lipopolysaccharide-Induced Up-Regulation of Triggering Receptor Expressed on Myeloid Cells-1 Expression on Macrophages Is Regulated by Endogenous Prostaglandin E2 J. Immunol., January 15, 2007; 178(2): 1144 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Netea, T. Azam, G. Ferwerda, S. E. Girardin, S.-H. Kim, and C. A. Dinarello Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors J. Leukoc. Biol., December 1, 2006; 80(6): 1454 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Phua, E. S. C. Koay, D. Zhang, L. K. Tai, X. L. Boo, K. C. Lim, and T. K. Lim Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections Eur. Respir. J., October 1, 2006; 28(4): 695 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kofoed, U. V. Schneider, T. Scheel, O. Andersen, and J. Eugen-Olsen Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP Technology Clin. Chem., July 1, 2006; 52(7): 1284 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Mahdy, D. A. Lowes, H. F. Galley, J. E. Bruce, and N. R. Webster Production of Soluble Triggering Receptor Expressed on Myeloid Cells by Lipopolysaccharide-Stimulated Human Neutrophils Involves De Novo Protein Synthesis Clin. Vaccine Immunol., April 1, 2006; 13(4): 492 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Carpenter, K. F. Buckland, Z. Xing, and C. M. Hogaboam Intrapulmonary, Adenovirus-Mediated Overexpression of KARAP/DAP12 Enhances Fungal Clearance during Invasive Aspergillosis Infect. Immun., December 1, 2005; 73(12): 8402 - 8406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Skogstrand, P. Thorsen, B. Norgaard-Pedersen, D. E. Schendel, L. C. Sorensen, and D. M. Hougaard Simultaneous Measurement of 25 Inflammatory Markers and Neurotrophins in Neonatal Dried Blood Spots by Immunoassay with xMAP Technology Clin. Chem., October 1, 2005; 51(10): 1854 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Correction: Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1 Ann Intern Med, April 5, 2005; 142(7): 592 - 592. [Full Text] [PDF]
|
|
|
|
|
|
S. Knapp, S. Gibot, A. de Vos, H. H. Versteeg, M. Colonna, and T. van der Poll Cutting Edge: Expression Patterns of Surface and Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Human Endotoxemia J. Immunol., December 15, 2004; 173(12): 7131 - 7134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gibot, M.-N. Kolopp-Sarda, M.-C. Bene, P.-E. Bollaert, A. Lozniewski, F. Mory, B. Levy, and G. C. Faure A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis J. Exp. Med., December 6, 2004; 200(11): 1419 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gibot and A. Cravoisy Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection Clin. Med. Res., August 1, 2004; 2(3): 181 - 187. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
